Glutamine is synthesized primarily in skeletal muscle, lungs, and adip
ose tissue. Plasma glutamine plays an important role as a carrier of n
itrogen, carbon, and energy between organs and is used for hepatic ure
a synthesis, for renal ammoniagenesis, for gluconeogenesis in both liv
er and kidney, and as a major respiratory fuel for many cells. The cat
abolism of glutamine is initiated by either of two isoforms of the mit
ochondrial glutaminase, Liver-type glutaminase is expressed only in pe
riportal hepatocytes of the postnatal liver, where it effectively coup
les ammonia production with urea synthesis. Kidney-type glutaminase is
abundant in kidney, brain, intestine, fetal liver, lympho-cytes, and
transformed cells, where the resulting ammonia is released without fur
ther metabolism. The two isoenzymes have different structural and kine
tic properties that contribute to their function and short-term regula
tion. Although there is a high degree of identity in amino acid sequen
ces, the two glutaminases are the products of different but related ge
nes. The two isoenzymes are also subject to long-term regulation. Hepa
tic glutaminase is increased during starvation, diabetes, and feeding
a high-protein diet, whereas kidney-type glutaminase is increased only
in kidney in response to metabolic acidosis. The adaptations in hepat
ic glutaminase are mediated by changes in the rate of transcription, w
hereas kidney-type glutaminase is regulated at a posttranscriptional l
evel.